We are live on ! Find out more
AL

Aspiriant LLC Portfolio holdings

AUM $4.05B
1-Year Est. Return 19.01%
This Fund
S&P 500
This Quarter Est. Return
+2.01%
1 Year Est. Return
+19.01%
3 Year Est. Return
+47.13%
5 Year Est. Return
+48.95%
10 Year Est. Return
+147.53%
AUM
$3.48B
AUM Growth
+$211M
Cap. Flow
+$149M
Cap. Flow %
4.28%
Top 10 Hldgs %
63.27%
Holding
329
New
32
Increased
177
Reduced
75
Closed
10

Sector Composition

Rank Sector Weight
1 Technology 4.12%
2 Financials 2.19%
3 Communication Services 1.35%
4 Healthcare 0.61%
5 Consumer Discretionary 0.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EEM icon
101
iShares MSCI Emerging Markets ETF
EEM
$28.1B
$2.18M 0.06%
39,780
+204
+0.5% +$11.1K
QCOM icon
102
Qualcomm
QCOM
$172B
$2.16M 0.06%
12,641
+376
+3% +$64.4K
AOM icon
103
iShares Core Moderate Allocation ETF
AOM
$1.75B
$2.16M 0.06%
45,218
ABBV icon
104
AbbVie
ABBV
$470B
$2.16M 0.06%
9,442
+207
+2% +$47.2K
V icon
105
Visa
V
$702B
$2.11M 0.06%
6,019
+1,241
+26% +$423K
ABT icon
106
Abbott
ABT
$187B
$2.1M 0.06%
16,738
-315
-2% -$40.1K
DGRO icon
107
iShares Core Dividend Growth ETF
DGRO
$43.3B
$2.09M 0.06%
30,167
+16,929
+128% +$1.16M
SCHB icon
108
Schwab US Broad Market ETF
SCHB
$42.9B
$2.09M 0.06%
79,715
+1,875
+2% +$48.8K
WFC icon
109
Wells Fargo
WFC
$263B
$2.03M 0.06%
21,782
+95
+0.4% +$8.25K
SDY icon
110
State Street SPDR S&P Dividend ETF
SDY
$22.3B
$2.03M 0.06%
14,553
-1,011
-6% -$141K
MA icon
111
Mastercard
MA
$497B
$1.98M 0.06%
3,467
+327
+10% +$183K
SHV icon
112
iShares 0-1 Year Treasury Bond ETF
SHV
$20.8B
$1.98M 0.06%
17,932
-898
-5% -$99K
BAC icon
113
Bank of America
BAC
$439B
$1.97M 0.06%
35,867
+2,791
+8% +$148K
COST icon
114
Costco
COST
$430B
$1.91M 0.06%
2,219
+188
+9% +$170K
VNQI icon
115
Vanguard Global ex-US Real Estate ETF
VNQI
$3.53B
$1.9M 0.05%
41,372
-147
-0.4% -$6.95K
MDY icon
116
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.9B
$1.88M 0.05%
3,123
-98
-3% -$58.6K
IWP icon
117
iShares Russell Mid-Cap Growth ETF
IWP
$19.6B
$1.88M 0.05%
13,757
+1,456
+12% +$203K
CVX icon
118
Chevron
CVX
$375B
$1.87M 0.05%
12,237
-1,143
-9% -$174K
ESML icon
119
iShares ESG Aware MSCI USA Small-Cap ETF
ESML
$2.83B
$1.85M 0.05%
+40,343
New +$1.84M
VYM icon
120
Vanguard High Dividend Yield ETF
VYM
$82B
$1.85M 0.05%
12,895
+1,262
+11% +$179K
AXP icon
121
American Express
AXP
$227B
$1.77M 0.05%
4,778
+430
+10% +$154K
LOW icon
122
Lowe's Companies
LOW
$122B
$1.75M 0.05%
7,261
+227
+3% +$54.5K
IBM icon
123
IBM
IBM
$213B
$1.75M 0.05%
5,906
+1,374
+30% +$411K
RTX icon
124
RTX Corp
RTX
$294B
$1.74M 0.05%
9,485
+57
+0.6% +$9.9K
HD icon
125
Home Depot
HD
$343B
$1.74M 0.05%
5,043
-562
-10% -$206K

Similar funds

Aspiriant LLC's Q4 2025 Portfolio in Review

As of Q4 2025, Aspiriant LLC held 329 positions worth $3.48B, up 6.4% from $3.27B the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Aspiriant LLC deployed $149M of net new capital in Q4 2025, opening 32 new positions and adding to 177 existing holdings. Its largest new stake was iShares Core MSCI International Developed Markets ETF: 102,726 shares worth $8.47M.

By sector, the portfolio is most concentrated in Technology at 4.1% of assets, up from 4% a quarter earlier, followed by Financials and Communication Services.

On the sell side, the largest reduction was iShares National Muni Bond ETF, an estimated $3.77M trimmed.

  • Aspiriant LLC's largest Q4 2025 buy was iShares Core MSCI International Developed Markets ETF: 102,726 shares worth $8.47M.
  • Aspiriant LLC added most to iShares Core S&P 500 ETF in Q4 2025, an estimated $20M increase.
  • Aspiriant LLC's biggest Q4 2025 reduction was iShares National Muni Bond ETF, cutting an estimated $3.77M.
  • Aspiriant LLC fully exited Vanguard Total International Bond ETF in Q4 2025, selling an estimated $906K.
  • Aspiriant LLC's ten largest holdings make up 63% of its $3.48B portfolio in Q4 2025.
  • Aspiriant LLC opened 32 new positions and closed 10 in Q4 2025.
  • Aspiriant LLC's portfolio value rose 6.4% quarter-over-quarter to $3.48B.

Based on Aspiriant LLC's 13F filing for Q4 2025, filed 20 Jan 2026.